1. Home
  2. ABTS vs CPHI Comparison

ABTS vs CPHI Comparison

Compare ABTS & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABTS
  • CPHI
  • Stock Information
  • Founded
  • ABTS 2010
  • CPHI N/A
  • Country
  • ABTS Hong Kong
  • CPHI China
  • Employees
  • ABTS N/A
  • CPHI N/A
  • Industry
  • ABTS Computer Software: Programming Data Processing
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABTS Technology
  • CPHI Health Care
  • Exchange
  • ABTS Nasdaq
  • CPHI Nasdaq
  • Market Cap
  • ABTS 4.6M
  • CPHI 5.4M
  • IPO Year
  • ABTS N/A
  • CPHI N/A
  • Fundamental
  • Price
  • ABTS $3.79
  • CPHI $2.22
  • Analyst Decision
  • ABTS
  • CPHI
  • Analyst Count
  • ABTS 0
  • CPHI 0
  • Target Price
  • ABTS N/A
  • CPHI N/A
  • AVG Volume (30 Days)
  • ABTS 366.3K
  • CPHI 85.3K
  • Earning Date
  • ABTS 12-31-2024
  • CPHI 05-23-2025
  • Dividend Yield
  • ABTS N/A
  • CPHI N/A
  • EPS Growth
  • ABTS N/A
  • CPHI N/A
  • EPS
  • ABTS N/A
  • CPHI N/A
  • Revenue
  • ABTS $6,711,225.00
  • CPHI $4,295,377.00
  • Revenue This Year
  • ABTS N/A
  • CPHI N/A
  • Revenue Next Year
  • ABTS N/A
  • CPHI N/A
  • P/E Ratio
  • ABTS N/A
  • CPHI N/A
  • Revenue Growth
  • ABTS 299.11
  • CPHI N/A
  • 52 Week Low
  • ABTS $0.25
  • CPHI $1.20
  • 52 Week High
  • ABTS $4.19
  • CPHI $4.10
  • Technical
  • Relative Strength Index (RSI)
  • ABTS 53.78
  • CPHI 56.97
  • Support Level
  • ABTS $2.91
  • CPHI $2.08
  • Resistance Level
  • ABTS $9.40
  • CPHI $2.50
  • Average True Range (ATR)
  • ABTS 1.01
  • CPHI 0.23
  • MACD
  • ABTS 0.03
  • CPHI 0.06
  • Stochastic Oscillator
  • ABTS 21.54
  • CPHI 63.64

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: